Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 985 of 1,261
  1. US 7816532

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  2. US 7816086

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  3. US 7815921

    Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

    Ludwig-Maximilians-Universitat Munchen · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  4. US 7815914

    Methods for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  5. US 7815434

    Dental coating kit

    Kuraray Medical Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  6. DO P2009000148

    DERIVADOS DE ESTER Y AMIDA DE INDAZOLILO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR UN RECEPTOR DE GLUCOCORTICOIDES

    BAYER SCHERING PHARMA AG [DE] · Granted Oct 15, 2010 · Expires Oct 10, 2030

    granted
  7. US 7812150

    RNAi modulation of Aha and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  8. US 7812132

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  9. US 7812174

    Methods of preparing imidazole-based compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  10. US 7812199

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  11. US 7812117

    Vasostatin as marrow protectant

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  12. US 7812168

    Purification of montelukast

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  13. US 7811996

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

    The Regents of the University of California · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  14. US 7812044

    Anticancer agents

    Takeda Pharmaceutical Company Limited · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  15. US 7811297

    Actuable structures and methods of fabrication and use

    TELEDYNE SCIENTIFIC & IMAGING, LLC · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  16. US 7812025

    Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder

    Takeda Pharmaceutical Company Limited · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  17. US 7811998

    Novobiocin analogues as anticancer agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  18. US 7811622

    Coated implantable medical device

    Cook Regentec LLC · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  19. US 7812029

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  20. US 7811592

    Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

    The Board of Regents of the University of Texas System · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  21. US 7811563

    Anti-addl antibodies and uses thereof

    Northwestern University · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  22. US 7811602

    Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

    Tekmira Pharmaceuticals Corporation · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  23. US 7811550

    Method for making magnetic fluorescent core shell nanoparticles

    United States of America as represented by the Secretary of the Air Force · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  24. US 7811603

    Microfluidic device for forming monodisperse lipoplexes

    The Regents of the University of California · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.